Cover Image

Microdose Cocktail Study Reveals the Activity and Key Influencing Factors of OATP1B , P‐Gp, BCRP, and CYP3A in End‐Stage Renal Disease Patients

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Weijie Kong, Yuejuan Pan, Yujie Wu, Yiyi Hu, Zhenbin Jiang, Xinkui Tian, Shuhong Bi, Song Wang, Feifei Feng, Yuyan Jin, Jiayu Li, Haiyan Li, Yue Wang, Hao Liang, Wen Tang, Dongyang Liu
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Clinical Pharmacology & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comprehensive Evaluation of OATP‐ and BCRP‐Mediated Drug–Drug Interactions of Methotrexate Using Physiologically‐Based Pharmacokinetic Modeling
by: Sejung Hwang, et al.
Published: (2024)

Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay
by: Yi‐An Bi, et al.
Published: (2024)

In vitro screening model for compound interactions with human and dairy animal BCRP orthologs
by: Lérica Le Roux‐Pullen, et al.
Published: (2024)

Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)
by: Andrew M. Riselli, et al.
Published: (2025)

Navigating the Challenges of Cyclosporine as an Alternative to Rifampicin as an OATP1B Index Inhibitor
by: Manthena V. S. Varma, et al.
Published: (2025)

Structural Connectivity Disruption and Structural–Functional Decoupling in Working Memory Networks Across Pre‐Dialysis and Maintenance Hemodialysis End‐Stage Renal Disease Patients
by: Xiaoling Xu, et al.
Published: (2026)

A Clinical Practice Perspective on the Evaluation of OATP1B1‐associated Drug Interactions
by: Céline K. Stäuble, et al.
Published: (2024)

Assessment of Angiography‐Based Renal Quantitative Flow Ratio Measurement in Patients with Atherosclerotic Renal Artery Stenosis
by: Xiang Huang, et al.
Published: (2024)

Recent Advances in Renal Denervation Therapy and Novel Applications of High‐Intensity Focused Ultrasound
by: JunHao Wang, et al.
Published: (2025)

Repeated Intake of Grapefruit Juice Inhibits CYP2B6 , CYP2C9 , CYP2C19 , and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans
by: Laura Aurinsalo, et al.
Published: (2025)

Aging‐Related CYP3A Functional Changes in Chinese Older Patients: New Findings from Model‐Based Assessment of Amlodipine
by: Jie En Valerie Sia, et al.
Published: (2024)

Biomarker‐Based Prediction of OATP1B1 Activity in Clinical Routine—Investigating Coproporphyrins as Markers for Drug–Drug–Gene Interactions
by: Leila Potzel, et al.
Published: (2026)

Cocktail Polyplexes With Synchronous Flightless I siRNA and Nitric Oxide Release for Potential Chronic Wound Healing
by: Mahshid Kharaziha, et al.
Published: (2024)

The role of glutamate and glutamine metabolism and related transporters in nerve cells
by: Dongyang Zhang, et al.
Published: (2024)

Population Pharmacokinetic Modeling of Glycochenodeoxycholic Acid 3‐O‐Sulfate ( GCDCA ‐S) as Endogenous Biomarker of OATP1B3 and OAT3 Transporters
by: Yuki Ujihira, et al.
Published: (2025)

An Evaluation of the Drug Interaction Potential of Encorafenib in Combination With Binimetinib Using the Inje Cocktail in Patients With Cancer
by: Joseph Piscitelli, et al.
Published: (2025)

miR‐484 in Hippocampal Astrocytes of Aged and Young Rats Targets CSF‐1 to Regulate Neural Progenitor/Stem Cell Proliferation and Differentiation Into Neurons
by: Jiahua Qu, et al.
Published: (2025)

Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention
by: Danwei Shao, et al.
Published: (2026)

Frequency of Key Pharmacogenes CYP2C9 , CYP2C19 , CYP2D6 , and SLCO1B1 in the Yogyakarta Population: Implications for Precision Prescribing in Indonesia
by: Dwi Aris Agung Nugrahaningsih, et al.
Published: (2026)

Application and Quality of Model‐Based Meta‐Analysis in Pharmaceutical Research: A Systematic Cross‐Sectional Analysis and Practical Considerations
by: Zhirong Yang, et al.
Published: (2024)

Angiotensin Receptor–Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction
by: Xiaogang Zhu, et al.
Published: (2024)

Use ofCYP2D6Inhibitors withCYP2D6Opioids: Association with Emergency Department Visits for Pain
by: Noor Ahmed Nahid, et al.
Published: (2024)

PharmVar GeneFocus: CYP4F2
by: Pablo Zubiaur, et al.
Published: (2024)

Dehydrocostus Lactone Inhibits Microglia‐Mediated Neuroinflammation by Targeting CYP2A6 to Improve Ischemic Brain Injury
by: Xin Shu, et al.
Published: (2025)

Editorial: Extracellular Matrix Biomarkers Illuminate the Architecture of Portal Hypertension in End‐Stage Liver Disease—Authors' Reply
by: Mattias Mandorfer, et al.
Published: (2025)

Population Pharmacokinetics of Tigecycline in Critically Ill Patients and Optimal Dosage Regimens With Dose Simulations Based on Infection Type and Renal Function
by: Fen Yao, et al.
Published: (2025)

A Comparative Study of Therapeutic Effects of Mannose and Umbilical Cord Mesenchymal Stem Cells in the Treatment of Late‐Stage Diabetes
by: Kun Zhang, et al.
Published: (2025)

Integrative Network Pharmacology and Bulk RNA‐Seq Unveil Berberine's Modulation of Mitochondrial Function and Oxidative Stress via SOD2 in Experimental Models of Ovarian Cancer
by: Yujie Cheng, et al.
Published: (2025)

Physiologically Based Pharmacokinetic Modeling to Investigate the Disease‐Drug–Drug Interactions between Voriconazole and Nirmatrelvir/Ritonavir in COVID‐19 Patients with CYP2C19 Phenotypes
by: Peile Wang, et al.
Published: (2024)

Correction to “Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals”
Published: (2024)

Impact of CYP2C19 Genotype on Sertraline and Escitalopram Exposure and Antidepressant Switching Rate: A Retrospective Cohort Study of Chinese Han Patients
by: Yuhang Yan, et al.
Published: (2025)

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2B6 Genotype and Methadone Therapy
by: Katherine M. Robinson, et al.
Published: (2024)

Phenoconversion Due to Drug–Drug Interactions in CYP2C19 Genotyped Healthy Volunteers
by: Kenza Abouir, et al.
Published: (2024)

Population Pharmacokinetics of Trimethoprim/Sulfamethoxazole: Dosage Optimization for Patients with Renal Insufficiency or Receiving Continuous Renal Replacement Therapy
by: Emiel Leegwater, et al.
Published: (2024)

Correspondence of Basal Forebrain Resting‐State Functional Connectivity and Cerebral Glucose Metabolism Alterations With Neurotransmitter Maps in Alzheimer's Disease
by: Yujie He, et al.
Published: (2026)

Electrophysiological Alterations in the Progression of Parkinson's Disease and the Therapeutic Effect of Tetrabenazine on Rats With Levodopa‐Induced Dyskinesia
by: Yuewei Bi, et al.
Published: (2025)

CYP2C19 Genotype is Associated with Citalopram Treatment Outcomes in a Real‐World Setting
by: Yoomi Park, et al.
Published: (2026)

Age‐Dependent Abundance of CYP450 Enzymes Involved in Metronidazole Metabolism: Application to Pediatric PBPK Modeling
by: Md Masud Parvez, et al.
Published: (2024)

Congenital Hypothyroidism Dysregulates TRPC6 to Mediate Abnormal Dendritic Spine Growth of Hippocampal Neurons
by: Tianci Li, et al.
Published: (2025)

Comparison of Regression and Categorical Analysis for Pharmacokinetic Data From Renal Impairment Studies
by: Gerald Chun‐To So, et al.
Published: (2025)